13 Small Cap Stocks Analysts Are Bullish On

Page 8 of 12

5. Praxis Precision Medicines, Inc. (NASDAQ:PRAX)

Market Cap: $862.42 million

Analyst Upside: 94.85%

Number of Hedge Fund Holders: 33

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is one of the 13 Small Cap Stocks Analysts Are Bullish On. On June 12, Truist Financial analyst Joon Lee maintained a Buy rating on Praxis Precision Medicines, Inc. (NASDAQ:PRAX) without a price target.

The company reported in its fiscal Q1 2025 results that it is on track for six major study readouts across four programs over 12 months, and is ready to start the pivotal studies in two developmental and epileptic encephalopathy (DEE) programs in mid-year 2025. These include the EMERALD for broad DEEs with relutrigine and EMBRAVE3 for SCN2A GoF with elsunersen.

Management anticipates topline near-term results for vormatrigine from the RADIANT study in epilepsy by mid-2025, along with the POWER1 study in H2 2025. Vormatrigine is continuing to exhibit competitive differentiation and an ideal profile, bringing a positive light to Praxis Precision Medicines, Inc. (NASDAQ:PRAX).

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is a clinical-stage biopharmaceutical company that develops therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company focuses on two proprietary platforms: Cerebrum and Solidus.

Page 8 of 12